IBDEI1IW ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,24652,2)
;;=^5002455
;;^UTILITY(U,$J,358.3,24653,0)
;;=B19.10^^85^1086^26
;;^UTILITY(U,$J,358.3,24653,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24653,1,3,0)
;;=3^Hepatitis B w/o Hepatic Coma
;;^UTILITY(U,$J,358.3,24653,1,4,0)
;;=4^B19.10
;;^UTILITY(U,$J,358.3,24653,2)
;;=^5000552
;;^UTILITY(U,$J,358.3,24654,0)
;;=B17.10^^85^1086^27
;;^UTILITY(U,$J,358.3,24654,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24654,1,3,0)
;;=3^Hepatitis C w/o Hepatic Coma,Acute
;;^UTILITY(U,$J,358.3,24654,1,4,0)
;;=4^B17.10
;;^UTILITY(U,$J,358.3,24654,2)
;;=^5000542
;;^UTILITY(U,$J,358.3,24655,0)
;;=B18.2^^85^1086^28
;;^UTILITY(U,$J,358.3,24655,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24655,1,3,0)
;;=3^Hepatitis C,Chr/Carrier
;;^UTILITY(U,$J,358.3,24655,1,4,0)
;;=4^B18.2
;;^UTILITY(U,$J,358.3,24655,2)
;;=^5000548
;;^UTILITY(U,$J,358.3,24656,0)
;;=E03.9^^85^1086^42
;;^UTILITY(U,$J,358.3,24656,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24656,1,3,0)
;;=3^Hypothyroidism,Unspec
;;^UTILITY(U,$J,358.3,24656,1,4,0)
;;=4^E03.9
;;^UTILITY(U,$J,358.3,24656,2)
;;=^5002476
;;^UTILITY(U,$J,358.3,24657,0)
;;=E16.2^^85^1086^39
;;^UTILITY(U,$J,358.3,24657,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24657,1,3,0)
;;=3^Hypoglycemia,Unspec
;;^UTILITY(U,$J,358.3,24657,1,4,0)
;;=4^E16.2
;;^UTILITY(U,$J,358.3,24657,2)
;;=^5002708
;;^UTILITY(U,$J,358.3,24658,0)
;;=E78.1^^85^1086^34
;;^UTILITY(U,$J,358.3,24658,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24658,1,3,0)
;;=3^Hyperglyceridemia,Pure
;;^UTILITY(U,$J,358.3,24658,1,4,0)
;;=4^E78.1
;;^UTILITY(U,$J,358.3,24658,2)
;;=^101303
;;^UTILITY(U,$J,358.3,24659,0)
;;=E78.5^^85^1086^37
;;^UTILITY(U,$J,358.3,24659,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24659,1,3,0)
;;=3^Hyperlipidemia,Unspec
;;^UTILITY(U,$J,358.3,24659,1,4,0)
;;=4^E78.5
;;^UTILITY(U,$J,358.3,24659,2)
;;=^5002969
;;^UTILITY(U,$J,358.3,24660,0)
;;=E87.1^^85^1086^38
;;^UTILITY(U,$J,358.3,24660,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24660,1,3,0)
;;=3^Hypo-osmolatlity & Hyponatremia
;;^UTILITY(U,$J,358.3,24660,1,4,0)
;;=4^E87.1
;;^UTILITY(U,$J,358.3,24660,2)
;;=^5003019
;;^UTILITY(U,$J,358.3,24661,0)
;;=E87.5^^85^1086^35
;;^UTILITY(U,$J,358.3,24661,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24661,1,3,0)
;;=3^Hyperkalemia
;;^UTILITY(U,$J,358.3,24661,1,4,0)
;;=4^E87.5
;;^UTILITY(U,$J,358.3,24661,2)
;;=^60041
;;^UTILITY(U,$J,358.3,24662,0)
;;=E87.6^^85^1086^40
;;^UTILITY(U,$J,358.3,24662,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24662,1,3,0)
;;=3^Hypokalemia
;;^UTILITY(U,$J,358.3,24662,1,4,0)
;;=4^E87.6
;;^UTILITY(U,$J,358.3,24662,2)
;;=^60610
;;^UTILITY(U,$J,358.3,24663,0)
;;=G81.90^^85^1086^19
;;^UTILITY(U,$J,358.3,24663,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24663,1,3,0)
;;=3^Hemiplegia,Unspec
;;^UTILITY(U,$J,358.3,24663,1,4,0)
;;=4^G81.90
;;^UTILITY(U,$J,358.3,24663,2)
;;=^5004120
;;^UTILITY(U,$J,358.3,24664,0)
;;=G81.91^^85^1086^18
;;^UTILITY(U,$J,358.3,24664,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24664,1,3,0)
;;=3^Hemiplegia Affecting Right Dominant Side
;;^UTILITY(U,$J,358.3,24664,1,4,0)
;;=4^G81.91
;;^UTILITY(U,$J,358.3,24664,2)
;;=^5004121
;;^UTILITY(U,$J,358.3,24665,0)
;;=G81.92^^85^1086^17
;;^UTILITY(U,$J,358.3,24665,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24665,1,3,0)
;;=3^Hemiplegia Affecting Left Dominant Side
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1IW 3804 printed Apr 09, 2024@21:26:18 Page 2
IBDEI1IW ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,24652,2)
+2 ;;=^5002455
+3 ;;^UTILITY(U,$J,358.3,24653,0)
+4 ;;=B19.10^^85^1086^26
+5 ;;^UTILITY(U,$J,358.3,24653,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,24653,1,3,0)
+8 ;;=3^Hepatitis B w/o Hepatic Coma
+9 ;;^UTILITY(U,$J,358.3,24653,1,4,0)
+10 ;;=4^B19.10
+11 ;;^UTILITY(U,$J,358.3,24653,2)
+12 ;;=^5000552
+13 ;;^UTILITY(U,$J,358.3,24654,0)
+14 ;;=B17.10^^85^1086^27
+15 ;;^UTILITY(U,$J,358.3,24654,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,24654,1,3,0)
+18 ;;=3^Hepatitis C w/o Hepatic Coma,Acute
+19 ;;^UTILITY(U,$J,358.3,24654,1,4,0)
+20 ;;=4^B17.10
+21 ;;^UTILITY(U,$J,358.3,24654,2)
+22 ;;=^5000542
+23 ;;^UTILITY(U,$J,358.3,24655,0)
+24 ;;=B18.2^^85^1086^28
+25 ;;^UTILITY(U,$J,358.3,24655,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,24655,1,3,0)
+28 ;;=3^Hepatitis C,Chr/Carrier
+29 ;;^UTILITY(U,$J,358.3,24655,1,4,0)
+30 ;;=4^B18.2
+31 ;;^UTILITY(U,$J,358.3,24655,2)
+32 ;;=^5000548
+33 ;;^UTILITY(U,$J,358.3,24656,0)
+34 ;;=E03.9^^85^1086^42
+35 ;;^UTILITY(U,$J,358.3,24656,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,24656,1,3,0)
+38 ;;=3^Hypothyroidism,Unspec
+39 ;;^UTILITY(U,$J,358.3,24656,1,4,0)
+40 ;;=4^E03.9
+41 ;;^UTILITY(U,$J,358.3,24656,2)
+42 ;;=^5002476
+43 ;;^UTILITY(U,$J,358.3,24657,0)
+44 ;;=E16.2^^85^1086^39
+45 ;;^UTILITY(U,$J,358.3,24657,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,24657,1,3,0)
+48 ;;=3^Hypoglycemia,Unspec
+49 ;;^UTILITY(U,$J,358.3,24657,1,4,0)
+50 ;;=4^E16.2
+51 ;;^UTILITY(U,$J,358.3,24657,2)
+52 ;;=^5002708
+53 ;;^UTILITY(U,$J,358.3,24658,0)
+54 ;;=E78.1^^85^1086^34
+55 ;;^UTILITY(U,$J,358.3,24658,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,24658,1,3,0)
+58 ;;=3^Hyperglyceridemia,Pure
+59 ;;^UTILITY(U,$J,358.3,24658,1,4,0)
+60 ;;=4^E78.1
+61 ;;^UTILITY(U,$J,358.3,24658,2)
+62 ;;=^101303
+63 ;;^UTILITY(U,$J,358.3,24659,0)
+64 ;;=E78.5^^85^1086^37
+65 ;;^UTILITY(U,$J,358.3,24659,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,24659,1,3,0)
+68 ;;=3^Hyperlipidemia,Unspec
+69 ;;^UTILITY(U,$J,358.3,24659,1,4,0)
+70 ;;=4^E78.5
+71 ;;^UTILITY(U,$J,358.3,24659,2)
+72 ;;=^5002969
+73 ;;^UTILITY(U,$J,358.3,24660,0)
+74 ;;=E87.1^^85^1086^38
+75 ;;^UTILITY(U,$J,358.3,24660,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,24660,1,3,0)
+78 ;;=3^Hypo-osmolatlity & Hyponatremia
+79 ;;^UTILITY(U,$J,358.3,24660,1,4,0)
+80 ;;=4^E87.1
+81 ;;^UTILITY(U,$J,358.3,24660,2)
+82 ;;=^5003019
+83 ;;^UTILITY(U,$J,358.3,24661,0)
+84 ;;=E87.5^^85^1086^35
+85 ;;^UTILITY(U,$J,358.3,24661,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,24661,1,3,0)
+88 ;;=3^Hyperkalemia
+89 ;;^UTILITY(U,$J,358.3,24661,1,4,0)
+90 ;;=4^E87.5
+91 ;;^UTILITY(U,$J,358.3,24661,2)
+92 ;;=^60041
+93 ;;^UTILITY(U,$J,358.3,24662,0)
+94 ;;=E87.6^^85^1086^40
+95 ;;^UTILITY(U,$J,358.3,24662,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,24662,1,3,0)
+98 ;;=3^Hypokalemia
+99 ;;^UTILITY(U,$J,358.3,24662,1,4,0)
+100 ;;=4^E87.6
+101 ;;^UTILITY(U,$J,358.3,24662,2)
+102 ;;=^60610
+103 ;;^UTILITY(U,$J,358.3,24663,0)
+104 ;;=G81.90^^85^1086^19
+105 ;;^UTILITY(U,$J,358.3,24663,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,24663,1,3,0)
+108 ;;=3^Hemiplegia,Unspec
+109 ;;^UTILITY(U,$J,358.3,24663,1,4,0)
+110 ;;=4^G81.90
+111 ;;^UTILITY(U,$J,358.3,24663,2)
+112 ;;=^5004120
+113 ;;^UTILITY(U,$J,358.3,24664,0)
+114 ;;=G81.91^^85^1086^18
+115 ;;^UTILITY(U,$J,358.3,24664,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,24664,1,3,0)
+118 ;;=3^Hemiplegia Affecting Right Dominant Side
+119 ;;^UTILITY(U,$J,358.3,24664,1,4,0)
+120 ;;=4^G81.91
+121 ;;^UTILITY(U,$J,358.3,24664,2)
+122 ;;=^5004121
+123 ;;^UTILITY(U,$J,358.3,24665,0)
+124 ;;=G81.92^^85^1086^17
+125 ;;^UTILITY(U,$J,358.3,24665,1,0)
+126 ;;=^358.31IA^4^2
+127 ;;^UTILITY(U,$J,358.3,24665,1,3,0)
+128 ;;=3^Hemiplegia Affecting Left Dominant Side
